MODULE 2: LECTURE 4 NOTES
Overview of CRISPR and Genetic Disorders
CRISPR Technology: Powerful genetic tool used for editing DNA to correct genetic disorders.
Cystic Fibrosis Award: Recently awarded scientists for advancements in understanding and treating cystic fibrosis through genetic editing.
Impact of Metabolic Disorders
Case Study: Highlights a specific child's struggle with a metabolic disorder caused by excess ammonia due to a genetic mutation.
Consequences: Significant organ damage affecting the brain, intestine, and liver can result from elevated ammonia levels, potentially leading to death.
CRISPR-Cas9 Therapy: Developed to address the genetic mutation rapidly and effectively in the child, transitioning CRISPR from laboratory research to clinical application.
Virus Mutation Concerns: Possible rapid mutation of viruses when using genetic editing tools in organisms could lead to increased spread of diseases.
Genetic Material and Transcription
Historical Context
RNA as Information Carrier: Historically, RNA was thought to be the primary genetic and information source.
Messenger RNA (mRNA): Serves as a template for protein synthesis.
Transcription Process
Comparison of Prokaryotes and Eukaryotes:
Prokaryotes: Transcription and translation occur in the same cellular compartment without organelles.
Eukaryotes: These processes are compartmentalized; transcription occurs in the nucleus, and translation occurs in the cytoplasm.
RNA Synthesis Nomenclature
Directionality of RNA: RNA is synthesized in a 5' to 3' direction, reflecting sequence order and allowing for proper complementary strand pairing.
Template Strand Identification: Students should determine which DNA strand serves as the template for RNA synthesis based on transcription directionality.
Complementary Strand Nomenclature
Template Strand vs Non-template Strand:
The non-template strand (coding strand) has thymine (T) while the RNA transcript uses uracil (U).
Noticeable similarity between the RNA strand and the non-template strand except for T (in DNA) and U (in RNA).
Transcription Initiation Complexity
Gene Structure
Transcribed Regions:
Genes can be coded on either strand of a double-stranded DNA molecule. For example, genes A and B may transcribe in opposite directions.
Promoter Sequences
Definition: Specific DNA sequences that signal the start of transcription.
TATA Box: A conserved sequence in many promoters that is crucial for initiating transcription, usually located about 25 base pairs upstream of the transcription start site.
Transcription Factors: Bind to promoter sequences and facilitate the recruitment of RNA polymerase.
Enhancers and Silencers
Definition of Enhancer Sequences: DNA elements that enhance transcription efficiency, can be located at various distances from the promoter.
Binding of Transcriptional Activators: Activators bind to enhancers to enhance the transcription process; a complex interaction occurs between different proteins and DNA sequences to start transcription.
Transcription Complex Formation
Assembly of Transcription Complex
Role of TBP (TATA Box Binding Protein):
Recognizes TATA box and recruits general transcription factors to form a transcription complex.
Mediator Role: Connects transcriptional activators to the transcription machinery at the promoter, facilitating RNA polymerase recruitment.
Elongation Phase
Initiation to Elongation Transition: Following initiation of transcription, the elongation phase begins, in which RNA polymerase synthesizes RNA using the DNA template strand.
Directionality During Elongation: Continues in a 5' to 3' direction; building RNA transcript in the proper sequence based on the template strand.